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ABSTRACT
OBJECTIVE: The new regulatory framework for dietary supplements in Brazil prompted this 
analysis of the current outlook of these products and the challenges posed by the new guidelines. 
METHODS: We conducted a qualitative, observational and descriptive study of dietary 
supplements commercialized in Brazilian online stores with the help of the Google® search tool. 
We considered the ingredients on the labels, the effects attributed to these products and the 
commercial claims used as a means of promoting them to assess the necessary changes for the 
legal framework in the new guidelines. Finally, with the help of a database, we compared the 
effects declared by the manufacturers and attributed to certain ingredients with the scientific 
evidence described in literature.
RESULTS: In total, we purchased 44 dietary supplements from Brazilian online stores (n = 7). 
Of the samples studied, 34.2% could not be classified in the category Dietary Supplements, 
as recommended by the new regulation of the Brazilian Health Regulatory Agency due to the 
presence of prohibited substances; 16% of products should be commercialized as medicines. 
Regarding the commercial appeals, 97.7% had banned expressions. Numerous claims of effects 
attributed to certain products were characterized as consumer fraud because they have no 
scientific evidence.
CONCLUSIONS: The necessary changes represent a major regulatory and production challenge 
due to the wide range of dietary supplements and markets, an effort that aims to protect the 
consumers’ health. Some previous gaps in the regulatory framework were not fully solved.
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INTRODUCTION
The consumption of dietary supplements has been increasing significantly in recent years 
and numerous reasons justify the phenomenon. Easy purchase in e-commerce and the 
social media’s strong influence are among the biggest impact factors. From 2010 to 2016, the 
consumption of dietary supplements in Brazil increased 233%, reaching a turnover of 1.49 
billion reais1. The large number of people consuming these products on their own initiative 
or through friend’s advice without the proper recommendation of a specialized professional 
has become a public health problem, worrying experts and authorities2. Literature reports 
numerous undesirable adverse effects, liver damage and even cases of death due to ingestion 
of dietary supplements3–5.
In Brazil, until 2018 dietary supplements had no legal definitions. According to the Brazilian 
Health Regulatory Agency (ANVISA ), most products used as dietary supplements were 
classified into different regulatory categories: (I) Food for athletes; (II) Vitamin and/or 
mineral supplements; (III) New foods and/or new ingredients; (IV) Food of functional and/or 
health property; (V) Specific medications; and (VI) Herbal medicines 6–11. The large number of 
products on the market makes inspection difficult, and the lack of safety for consumer health 
is the biggest risk associated with this outlook. This scenario favors the commercialization 
of dietary supplements containing proscribed substances in Brazil, such as ephedrine and 
1,3-dimethylamylamine12. Cases of dietary supplements deliberately adulterated to intensify 
the pharmacological effect and promote a false image that the product works are widely 
described in literature3,5,13–15. In addition, the lack of official methodologies in Brazil for this 
type of analysis makes the quality and safety of these products questionable. Consumer fraud 
was also connected to dietary supplements commercialized in Brazil due to divergences 
between the amount of carbohydrate and protein declared on labels and the actual values 
found after analysis by ANVISA16.
In recent years, ANVISA held several meetings to discuss and define regulation for dietary 
supplements. These debates originated the ANVISA RDC No. 243/2018, which defines 
the sanitary requirements for dietary supplements and is characterized as a regulatory 
framework in Brazil17. ANVISA also established the food additives and supporting 
technologies authorized for use in dietary supplements through ANVISA RDC No. 239 
of July 26, 201818. In contrast, the reference daily intake (RDI) values for vitamin, mineral 
and amino acid products are no longer the differentiating factor between vitamin and/or 
mineral supplements and specific medicines7,10. According to the new ANVISA RDC No. 
242/2018, only some products will be considered specific medicines: the vitamins and/or 
minerals and/or amino acids and/or protein based ones, isolated or associated with each 
other, for oral use, with well-established and therapeutic indications and different from the 
claims used in dietary supplements19.
The regularization of commercially available products under the new legal guidelines ranges 
from changes in label information to changes in the composition of dietary supplements. 
The regulated sector has five years to adapt to the new resolutions.
This study evaluated the main non-compliances observed on dietary supplement labels and 
verified whether the effects attributed to some ingredients had scientific evidence support. 
We also indicated the changes required by the new legislation for the most popular products 
commercialized in online stores. 
METHODS
Acquisition of samples
We conducted a retrospective, observational and descriptive study of the information 
collected from the purchase moment until the delivery of dietary supplement samples. 
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We purchased the samples from January to December 2017, before the regulatory 
framework for dietary supplements, and analyzed them according to the valid legislation 
at the time for this category of products. We also assessed non-compliance occurrences 
and required changes for the legal framework of the samples in the current guidelines. 
We considered relevant all the products that presented “food for athletes” or “dietary 
supplement for physically active people” as indication. We acquired the samples online, 
searched with the help of the Google® search tool. The e-commerce stores (n = 7) were all 
Brazilian, with Cadastro Nacional de Pessoa Jurídica (CNPJ – National Registry of Legal 
Entities), that declared the physical address on their websites and provided customer 
service. Sample prices ranged from R$ 19.50 to R$ 244.45. According to the available 
budget and the characteristics required to frame the product as a sample of interest, we 
could acquire 44 samples, which we received via mail. 
Sample Classification
The dietary supplements were distributed into categories designated according to ratings 
given by the websites (hormone modulation supplements, weight loss supplements, sexual 
performance supplements and muscle builders). The pertinent labeling information, such 
as ingredients, batch, manufacturer, images or expressions, information on exemption 
of sanitary registration according to ANVISA RDC No 27/201020 and indication for 
consumption, among others, were tabulated with the help of Microsoft Excel®. We assessed 
these data for compliance according to the valid legislation at the time of acquisition6–11. 
Subsequently, we analyzed the samples based on the new classification criteria for 
dietary supplements, permitted ingredients and claims referred in ANVISA RDC No. 
242 and 243/201817,19 and attachments. The claims attributed to the major ingredients 
of samples were compared with the recommendations of international societies and 
official organizations, such as the International Society of Sports Nutrition21, Academy of 
Nutrition and Dietetics, Dietitians of Canada and American College of Sports Medicine22, 
as well as scientific articles.
RESULTS
We named the effects that the e-commerce sites attributed to products as “commercial 
appeal.” According to the commercial appeals on the websites, the samples were classified 
into four main categories: (I) Hormonal Modulator/Precursor; (II) Weight Loss/Appetite 
Control/Diuresis; (III) Increased libido/sexual potency; and (IV) Muscle Builder/Performance 
Enhancer/Strength Gain. Chart 1 shows the frequency of these categories, as well as the 
effects attributed by manufacturers as a form of product advertising. The presence of more 
than one declared “active” ingredient on the label of some products was one of the main 
points we observed, which made the legal framework difficult in some legislations. Chart 
1 shows only the major ingredients, highlighting whey protein, natural ingredients (plant 
species) and vitamins and/or minerals as the most frequent.
According to the manufacturers, samples declared as hormone modulators (category I) 
(n = 13) were able to increase testosterone production or suggest the presence of precursor 
ingredients of this hormone. Six samples contained plant species prohibited in dietary 
supplements, such as Tribullus terrestris and Paullinia cupana, claiming to have herbal 
properties according to ANVISA RDC No. 26/201411 and the Brazilian pharmacopeia National 
Form23. Currently, according to the Normative Instruction (NI) ANVISA No. 28 of July 26, 
2018, Paullinia cupana is among the authorized constituents of dietary supplements as a 
caffeine source24. In the same category, two samples contained dehydroepiandrosterone 
(DHEA), a medicine whose use is controlled in Brazil according to Ordinance MS 
No.344/199825.
Among the samples alluding to weight loss (category II) (n = 8), all had commercial 
pharmacological action appeals such as “appetite suppressant” or “increased diuresis.” One 
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of the products that claimed to be exempted from registration as “Athlete Food” could not 
be legally classified in this category, as it declared Citrus aurantium on the label, a plant 
species that classifies the product as an anxiolytic herbal medicine. Its administration is 
recommended only for those over 12 years old, which therefore requires ANVISA registration 
for its commercialization11,23.
All supplements indicated to increase libido (category III) (n = 6) were in disagreement with 
the legislation as they attributed therapeutic effects to the products. Four of the supplements 
declared the presence of plant species, among them the herbal medicine Citrus aurantium11,23, 
Tribullus terrestris and Eurycoma longifolia. The last two are not available on the Herbal 
Medicines Form but are susceptible to registration due to the therapeutic claims presented26.
Supplements with muscle building claims or related to physical performance were the most 
frequent (category IV) (n = 17). Ten products were correctly classified as “Athlete Food,” 
considering the ingredients stated on the labels, which were exempt from registration6,20. 
Seven products had advertising alluding to anabolism, which is not allowed in food 
products6,27, for example, supplements containing only vitamins and/or minerals with 
claims such as: “Generates muscle mass and strength” or “Promotes muscle growth.” Two 
samples declared exemption from registration as they were called “Athlete Food”; However, 
due to the presence of substances that have no record of consumption in the country, such 
as the Peruvian ginseng (Lepidium meyenii), they should fall under the category “New foods 
and/or new ingredients”8,20. According to the legislation in force at the time of purchase 
of dietary supplements, two samples had non-nutrients or dietary fiber added, which was 
Chart 1. Frequency among product categories, effects attributed to the products observed on the label 
and the major ingredients of the studied dietary supplements.
Category % (n) Effects attributed to products
Main Ingredients
Description n
I
Hormonal 
modulator/
precursor
29.6 (13)
Precursor/
synthesis of/ 
enhancer/
increase of
Testosterone Zinc, Magnesium and Vitamin 
B6a 
DHEAb 
Tribullus terrestris
Peruvian ginseng
Chromium picolinate
7
2
2
1
1
II
Weight Loss/
Appetite Control/
Diuresis
18.2 (8)
Moderator Appetite Caffeine
Vitamins and/or minerals
Citrus aurantium
Psyllium (Plantago ovata)
3
3
1
1
Enhances/
Increases
Diuresis
Assists/
promotes
Weight loss
III
Increases / 
strengthens and 
combat / treatment 
of sexual potency/
libido
13.6 (6)
Increase/
Enhance
Virility and 
libido
Tribullus terrestris
Peruvian ginseng
Eurycoma longifolia
Zinc, Magnesium and Vitamin 
B6
2
2
1
1
Combat/
treatment of
Sexual 
impotence
IV
Assist / increase/
define and 
promote/ provides 
muscle Builder/
Performance 
Improvement/
Strength Gain
38.6 (17)
Assist/increase/
shape
Muscle Mass Whey Protein
BCAAc 
Paullinia cupana
Maltodextrin
Zinc, Magnesium and Vitamin 
B6
Beef Protein
7
3
2
2
2
1
Promotes/
Provides
Anabolic 
Effects
100 (44) Total 44
a Ingredient declared on the label in two ways: I) under the name ZMA; II) as nutrients added in different proportions. 
b Dehydroepiandrosterone. 
c Branched-chain amino acids. 
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prohibited, as per item IV of article 8 of ANVISA RDC No.18/20106. Under the new guidelines, 
this addition is possible as long as the substances are on the list of authorized constituents 
and the minimum, maximum limits and assigned claims are respected17,24.
Concerning the necessity of registration of samples with ANVISA, for both national 
and international products (n = 4), we performed a comparative analysis between what 
manufacturers stated on labels (Figure 1A) and the ideal declaration according to legislation 
in force at the time of production (Figure 1B)20.
Figure 2 shows the discrepancy of difference between the regulatory framework of products 
according to the information stated on the label (Figure 1A) and what the distribution 
between categories should be after analysis of  declared ingredients. Among the samples 
Figure 2. Distribution of samples evaluated according to regulatory categories, according to the legislation 
in force at the time of product acquisition.
Food of
functional and/or
health property
4%
Medicines
16%
New foods
and/or new
ingredients
18%
Vitamin
and/or mineral
supplements
23%
Athlete Foods
39%
Herbal
medicines
11%
Special Control
Medicines
5%
FDA – Food and Drug Administration.
Figure 1. Graphical representation of the evaluated sample records: (A) manufacturer declarations; (B) 
ideal declarations, in accordance with valid regulatory guidelines.
Exempt from 
registration 70%
FDA
Regulated
18%
Registration with
ANVISA 7%
Not declared 5%
Registration with
ANVISA 41%
Exempt from
registration 59%
A B
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that erroneously claimed to be exempt from registration were new foods, food of functional 
property and even medicines.
According to the new regulation, most products analyzed (70.5%, n = 29) were in compliance 
with the list of ingredients allowed in dietary supplements17,24. Some ingredients (Paullinia 
cupana and other non-nutrients in athlete food, for instance) that, until the time of the 
sample acquisition, were not legally protected to be added, are now allowed to be part of the 
dietary supplement constituents, respecting the necessary requirements17,24. On the other 
hand, 15 samples (34.2%) could not be commercialized as dietary supplements because 
they contain ingredients that are missing from the list of authorized constituents, such as 
Camellia sinensis, Lepidium meyenii, ginger, cinnamon powder, Trichilia catigua. Regarding 
the label, 97.7% of the samples were not in conformity due to the use of unauthorized 
expressions in dietary supplements, which attributed medicinal or therapeutic properties 
to the product, such as increased libido and diuretic action17,27. In addition, we also observed 
the use of images alluding to pharmacological effects such as weight loss or improved 
sexual performance17.
DISCUSSION
Label Analysis
Until 2018, the name “dietary supplement” was not provided by law and any product for 
this purpose was commercialized as food in several categories. We acquired the study 
samples before the Brazilian regulatory framework that defined the dietary supplements 
and whose main objective was to reduce regulatory fragmentation. Until then, sanitary 
registration was mandatory for “New foods,” “Foods with functional properties” and “Foods 
containing bioactive or probiotic substances,” while “Athlete foods” and “Vitamin and/or 
mineral supplements” were exempt from registration20.
The non-conformities found in the study samples were: (I) absence of product registration in 
the categories “New foods” (n = 8) and “Foods with functional property” (n = 1); (II) presence 
of ingredients that characterized the products as medicines (n = 7); (III) use of improper 
expressions and allegations (n = 43).
DHEA, for example, declared in two samples, is prohibited in dietary supplements 
commercialized in Brazil, as it is an anabolic steroid precursor, susceptible to special 
control25. By contrast, in the United States, this medicine is authorized in dietary 
supplements. However, numerous serious adverse effects are related to its consumption, 
such as tachycardia, arrhythmias, hepatotoxicity, among others28. In addition, five 
samples declared the presence of unauthorized plant species such as Tribullus terrestris 
and Citrus aurantium. However, only Citrus aurantium has safety and efficacy based on 
clinical evidence, characteristics attributed to herbal medicines11. The presence of banned 
substances in dietary supplements can cause serious public health problems. The user 
believes that it is a “natural product” and, therefore, will not harm health, which promotes 
excessive and often unnecessary consumption and may cause health damage, such as 
hepatotoxicity, cardiotoxicity and even death5,29.
Products commercialized as “Athlete Foods” had restrictions on the composition and 
addition of other substances, according to the intended use. Protein supplements, for 
example, conforming to previous legislation, could not contain fibers and non-nutrients. 
Caffeine supplements could not contain any nutrient or non-nutrient added in the 
formulation6. Due to the legislation in force at the time of samples acquisition, eight of them 
presented this type of non-compliance.
In Brazil, the addition of herbal medicines to athlete foods is prohibited11. We observed this 
non-compliance in a sample containing caffeine associated with Citrus aurantium. High 
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caffeine concentrations may promote toxic effects, such as nausea, vomiting, arrhythmias, 
tachycardia, and may even lead to death30. Synephrine is one of the active compounds in 
Citrus aurantium, often found in weight loss products. However, studies indicate possible 
cardiotoxicity related to indiscriminate consumption31. In Canada, for example, caffeine 
or caffeine sources addition to synephrine-containing products is banned due to the 
synergism of action, which may promote cardiotoxic effects, thus requiring proven safety 
evidence in humans32.
These label non-conformities serve as primary tools for assessing the quality of the product 
on the market. The inspection by the responsible bodies is fragile, probably due to the large 
number of available dietary supplements and stores, as well as the ease of purchase enabled 
by e-commerce. The difficulty of legal framing of the products by manufacturers, sellers and 
consumers was evident because of fragmented and unspecific regulation in force during 
the samples acquisition.
Commercial Appeals of Products
Commercial appeals are advertising tools designed to draw attention to possible 
benefits that the formulation or some specific component promotes in the body. Since its 
implementation, ANVISA RDC Resolution No. 259/2002 states that foods, regardless of 
category, cannot have indications of medicinal or therapeutic properties27. Expressions 
that refer to anabolism, catabolism, hypertrophy, fat burning, or increased sexual ability 
are vetoed on labels, advertisements, pamphlets, or other commercial tools for products 
classified as athlete food6 and are currently considered dietary supplements17. This 
non-compliance is susceptible to penalty, such as suspension of the product sale, fine 
and even website exclusion. In this study, we observed a significant number of samples 
with commercial appeals and misuse of expressions (97.7%). We suggest the following 
hypotheses: (I) High number of websites; (II) Difficulty to inspect online stores; (III) 
The exclusion of an inappropriate site is not a hindrance to the opening of another; 
(IV) Manufacturers are not always the ones who make the commercial appeals for the 
products, but the distributors, to increase sales. Using sentences that induce consumers 
to buy can be considered consumer fraud, as it is not always possible to guarantee that 
a particular ingredient will provide the expected result.
Effects Attributed to Main Ingredients and Their Scientific Evidence
Numerous substances are present in dietary supplements, but their presence is not always 
justified in consolidated scientific evidence. The effects attributed to the ingredients of 
these products are often not substantiated and sometimes inconsistent with those already 
described. Gaps in inspection contribute to the high number of products that deceive 
consumers with their miraculous effects, prompting them to buy. The regulatory framework 
emerged to attempt to reduce these gaps through a list of permitted claims related to the 
constituents of dietary supplements available in Attachment A of ANVISA Regulatory 
Instruction No. 28 of July 26, 201824. The frequent presence of ingredients from plants, 
vitamins and minerals in the samples and the image of “natural product” they convey is 
also relevant. The consumer generally believes that, for being a natural product, it is safe 
and will not harm the body13,14.
***According to Rocha et al. (2016)3, the great demand for these products is due to three 
factors: (I) growing distrust in conventional medicine, with a greater interest in alternative 
therapies; (II) the perception that they are “natural,” “healthy” products and safe, for being 
plant products; and (III) a growing trend of self-medication as a way to increase control 
over one’s health.
The addition of plants is directly related to the indication to reduce measures, diuresis 
or other claims that induce weight loss. However, a species may contain more than one 
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chemical, and an incorrect plant extraction may isolate unwanted metabolites. Thus, the 
addition of medicinal plants should be carefully observed.
Tribullus terrestris, declared in four samples, is a plant extract that has been connected to 
luteinizing hormone (LH) stimulation and consequent increase in testosterone33. Studies 
suggest that due to the presence of protodioscin, it has a steroid-like activity. However, no 
evidence shows that Tribullus terrestris or any single compound of this species promotes 
significant changes in body composition, such as lean mass gain or anabolism33.
Caffeine is a natural substance (1,3,7-trimethylxanthine) and widely consumed worldwide 
as a stimulant in dietary supplements, especially those indicated for “natural” weight loss. 
This methylxanthine is added with the commercial appeal of accelerating metabolism, 
stimulating diuresis and promoting fat burning. However, official positions detach caffeine 
from an increase in fat oxidation rate, but attribute caffeine to an increase in athlete 
performance as a potent brain stimulant21,22.
Protein foods for athletes have become popular among gym-goers for their association with 
lean mass gain. Whey protein is nothing more than the supernatant obtained from casein 
coagulation, accounting for 15-20% of total milk. The new regulation claims that “proteins 
help in the formation of muscles and bones”24. Protein supplements may be one of the few 
in accordance with scientific evidence for lean mass gain, as they help in muscle building. 
However, they are dissociated from testosterone levels or other ergogenic effects21,22,34. Claims 
found in seven samples, which used expressions referring to whey protein as capable of 
“increasing hormone levels” or as “an important precursor of testosterone.”
The branched-chain amino acids (BCAA), declared in three samples, also conquered their 
place inside the gyms. Consisting of leucine, isoleucine and valine, BCAA are consumed 
to reduce both physical and mental fatigue, improve performance and promote ergogenic 
effects such as anabolism. BCAA are responsible for tryptophan uptake and its conversion 
to serotonin, which is responsible for muscle fatigue35. However, the beneficial effects of 
this type of supplement are still divergent in the literature.
In Brazil, BCAA supplements, until the moment of acquisition of the samples, could not 
state indications for athletes or as athlete food, even with registration exemption6. However, 
we observed this non-compliance in all BCAA or BCAA-containing supplements (6.8%), as 
they were purchased with the athlete food specification.
Vitamins and minerals are dietary supplements intended to supplement the dietary 
needs of a healthy person, without the intention of replacing any food or being used 
as an exclusive diet7,19. At the time of the acquisition of samples, ANVISA’s regulation 
considered that vitamins and minerals were foods when they contained 25 to 100% of the 
reference daily intake (RDI) in the portion indicated on the label7. If the product contained 
doses with concentrations equivalent to more than 100% of the RDI, it was considered 
a specific medicine10. Currently, the new regulation considers vitamins and minerals as 
dietary supplements, regardless of the dose. They will be considered specific medicines 
only when they have well-established therapeutic claims, such as ferrous sulfate, which 
helps in deficiency anemias, and folic acid, which is indicated for reducing the occurrence 
of fetal malformations19.
Recently, the consumption of dietary supplements containing zinc and magnesium, 
especially among men, became popular due to the belief that this combination could 
increase testosterone levels and thus promote anabolic effects36. These minerals increase 
insulin-like growth factor (IGF-1) concentrations in children with disabilities; However, 
this claim has no proven evidence in healthy people37,38. We found claims in three samples 
that the combination of zinc, magnesium and vitamin B6, also known as ZMA, contained 
testosterone precursor substances. No scientific evidence shows that this supplement 
aids in training adaptations, promotes anabolic effects, or promotes significant effects on 
testosterone levels or metabolism21,39.
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The miraculous effect attributions to substances in dietary supplements, or even 
designations of “magic formulations,” are recurrent in these products. Manufacturers are 
not always the ones who attribute those claims, but rather shop owners as an advertising 
to boost sales. These miraculous attributions can also be an indication of the presence of 
prohibited substances in foods. The case of OxyElite Pro®, for example, which was widely 
disseminated because of its action on weight loss, contained 1,3-dimethylamylamine 
(DMAA), a highly harmful substance to the body. From February 2012 to February 2014, 114 
cases were reported to the Food and Drug Administration (FDA) of adverse effects related 
to the consumption of this supplement, characterizing a serious public health problem5,40.
Regularization of Products Available in the Market
The new legislation for Brazilian dietary supplements seeks to ensure quality consumer 
products with less regulatory hurdles for manufacturers. The products evaluated in this 
study need to undergo several changes to fit the new guidelines. These modifications range 
from composition (since current regulations provide a list of permitted ingredients and 
additives) to labeling regularization and claims used to promote the product17–19,24.
We observed a high frequency of advertisements about certain ingredients, which are not 
always true. These commercial appeals are intended to induce the consumer to buy or 
promote the false image that the product works. Regarding the allegations, according to 
the new legislation, of the 44 samples analyzed, only two would be in accordance with the 
rules set in Annex V of Normative Instruction No. 28, of July 26, 201817,24. Advertising rules 
are less complied by manufacturers and distributors due to the difficulty of regulatory 
agency inspection. It is often more advantageous for manufacturers to pay fines due 
to appealing claims as they boost sales and popularization of the product. The current 
regulatory system for dietary supplements aimed to reduce these non-compliances 
through the list of authorized constituents, their minimum and maximum limits and 
permitted claims. However, the new guidelines are not yet enabling tools for both 
industries and consumers because of some markers. For example, the manufacturer 
will define the appropriate quantities for daily consumption recommendations of the 
product and by population group in cases where minimum and maximum limits are 
not established17.
The growth in the number of dietary supplements available on the market, as well as the 
high number of stores, contributes to the inefficiency of the inspection of these products. 
The ease of purchase via e-commerce can make consumers have access to products that are 
illegal or that contain prohibited substances in dietary supplements. The user is not always 
aware of the damage these substances can cause, posing a public health challenge. Education 
policies that show the risks associated with unnecessary consumption, warnings that help 
to recognize the quality of dietary supplements, and research for a skilled professional before 
purchasing any of such products are good strategies for raising awareness and therefore 
reducing sales of illegal products or those that violate the law.
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